publication . Article . Other literature type . 2011

Association between C reactive protein and coronary heart disease

Wensley, F; Gao, P; Burgess, S; Kaptoge, S; Di Angelantonio, E; Shah, T; Engert, JC; Clarke, R; Davey-Smith, G; Nordestgaard, BG; ...
Open Access English
  • Published: 15 Feb 2011 Journal: BRITISH MEDICAL JOURNAL, volume 342, issue feb15 2 (issn: 0959-535X, eissn: 1468-5833, Copyright policy)
  • Country: United Kingdom
OBJECTIVE: To use genetic variants as unconfounded proxies of C reactive protein concentration to study its causal role in coronary heart disease. DESIGN: Mendelian randomisation meta-analysis of individual participant data from 47 epidemiological studies in 15 countries. PARTICIPANTS: 194 418 participants, including 46 557 patients with prevalent or incident coronary heart disease. Information was available on four CRP gene tagging single nucleotide polymorphisms (rs3093077, rs1205, rs1130864, rs1800947), concentration of C reactive protein, and levels of other risk factors. MAIN OUTCOME MEASURES: Risk ratios for coronary heart disease associated with genetical...
free text keywords: General Medicine, Science & Technology, Life Sciences & Biomedicine, Medicine, General & Internal, General & Internal Medicine, CARDIOVASCULAR-DISEASE, INSTRUMENTAL VARIABLES, MYOCARDIAL-INFARCTION, RISK, METAANALYSIS, ATHEROSCLEROSIS, MARKERS, GENE, POLYMORPHISMS, INFLAMMATION, Coronary Disease, Female, Gene Frequency, Humans, Male, Mendelian Randomization Analysis, Middle Aged, Polymorphism, Single Nucleotide, Prospective Studies, Risk Factors, C Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC), 1117 Public Health And Health Services, no, Research, Molecular Genetics, Drugs: Cardiovascular System, Ischaemic Heart Disease, UMCG Approved, C-reactive protein, biology.protein, biology, Internal medicine, medicine.medical_specialty, medicine, business.industry, business, Coronary heart disease, Cardiology
Related Organizations
35 references, page 1 of 3

1 Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685-95.15843671 [PubMed]

2 Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003;111:1805-12.12813013 [OpenAIRE] [PubMed]

3 Emerging Risk Factors Collaboration. C-reactive protein concentration and risk of coronary heart disease, stroke and mortality: an individual participant meta-analysis. Lancet 2010;375:132-40.20031199 [OpenAIRE] [PubMed]

4 De Beer FC, Soutar AK, Baltz ML, Trayner IM, Feinstein A, Pepys MB. Low density lipoprotein and very low density lipoprotein are selectively bound by aggregated C-reactive protein. J Exp Med 1982;156:230-42.7086355 [OpenAIRE] [PubMed]

5 Zhang YX, Cliff WJ, Schoefl GI, Higgins G. Coronary C-reactive protein distribution: its relation to development of atherosclerosis. Atherosclerosis 1999;145:375-9.10488966 [PubMed]

6 Bisoendial RJ, Boekholdt SM, Vergeer M, Stroes ES, Kastelein JJ. C-reactive protein is a mediator of cardiovascular disease. Eur Heart J 2010;31:2087-91.20685682 [PubMed]

7 Anand SS, Yusuf S. C-reactive protein is a bystander of cardiovascular disease. Eur Heart J 2010;31:2092-6.20675658 [PubMed]

8 Dav ey Smith G, Ebrahim S. What can Mendelian randomisation tell us about modifiable behavioural and environmental exposures? BMJ 2005;330:1076-9.15879400 [OpenAIRE] [PubMed]

9 Cohen JC, Boerwinkle E, Mosley TH Jr, Hobbs HH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 2006;354:1264-72.16554528 [PubMed]

10 Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 2009;301:2331-9.19509380 [PubMed]

11 Keavney B, Danesh J, Parish S, Palmer A, Clark S, Youngman L, et al. Fibrinogen and coronary heart disease: test of causality by “Mendelian randomization.” Int J Epidemiol 2006;35:935-43.16870675 [PubMed]

12 Kardys I, de Maat MP, Uitterlinden AG, Hofman A, Witteman JC. C-reactive protein gene haplotypes and risk of coronary heart disease: the Rotterdam Study. Eur Heart J 2006;27:1331-7.16682383 [PubMed]

13 Lange LA, Carlson CS, Hindorff LA, Lange EM, Walston J, Durda JP, et al. Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA 2006;296:2703-11.17164456 [PubMed]

14 Casas JP, Shah T, Cooper J, Hawe E, McMahon AD, Gaffney D, et al. Insight into the nature of the CRP-coronary event association using Mendelian randomization. Int J Epidemiol 2006;35:922-31.16565153 [PubMed]

15 Pai JK, Mukamal KJ, Rexrode KM, Rimm EB. C-reactive protein (CRP) gene polymorphisms, CRP levels, and risk of incident coronary heart disease in two nested case-control studies. PLoS One 2008;3:e1395.18167554 [OpenAIRE] [PubMed]

35 references, page 1 of 3
Any information missing or wrong?Report an Issue